Skip to menu Skip to content Skip to footer
Associate Professor David Vesey
Associate Professor

David Vesey

Email: 

Overview

Background

David graduated from the University of London with a BSc (Hons) in biochemistry (King’s College) and PhD which investigated the role of epidermal growth factor receptors in liver regeneration (Imperial College). Since then he has worked on a variety of projects including; immunoassay development (Ortho Clinical Diagnostics); artificial liver machine development (Imperial College); and p53 mutations in liver cancer (QIMR). He joined the Department of Nephrology at the Princess Alexandra Hospital in Brisbane in 1999. He is a senior lecturer in The University of Queensland Faculty of Medicine, a senior member of the UQ Kidney Disease Research Laboratory and manages the Princess Alexandra Hospital Endotoxin Testing Service.

His main research interests are in the area of renal tubulointerstitial fibrosis, inflammation and also the mechanisms of renal cancer development – particularly the role that cytokines and growth factors play in these processes. Current projects include the role of protease activated receptor-2 in renal scarring, inflammation and cancer, the mechanism of heavy metal toxicity in the kidney and the renoprotective properties of erythropoietin. The Princess Alexandra Hospital Endotoxin Testing Service routinely tests samples from dialysis units throughout Queensland.

Availability

Associate Professor David Vesey is:
Available for supervision

Fields of research

Qualifications

  • Bachelor of Biochemistry, King's College London
  • Doctor of Philosophy of Gastroenterology and Hepatology, Imperial College London

Works

Search Professor David Vesey’s works on UQ eSpace

169 works between 1991 and 2024

1 - 20 of 169 works

2024

Journal Article

Environmental Cadmium Exposure Induces an Increase in Systolic Blood Pressure by Its Effect on GFR

Satarug, Soisungwan, Vesey, David A., Yimthiang, Supabhorn, Khamphaya, Tanaporn, Pouyfung, Phisit and Đorđević, Aleksandra Buha (2024). Environmental Cadmium Exposure Induces an Increase in Systolic Blood Pressure by Its Effect on GFR. Stresses, 4 (3), 436-451. doi: 10.3390/stresses4030029

Environmental Cadmium Exposure Induces an Increase in Systolic Blood Pressure by Its Effect on GFR

2024

Journal Article

PAR2 activation on human tubular epithelial cells engages converging signaling pathways to induce an inflammatory and fibrotic milieu

Vesey, David A., Iyer, Abishek, Owen, Evan, Kamato, Danielle, Johnson, David W., Gobe, Glenda C., Fairlie, David P. and Nikolic-Paterson, David J. (2024). PAR2 activation on human tubular epithelial cells engages converging signaling pathways to induce an inflammatory and fibrotic milieu. Frontiers in Pharmacology, 15 1382094. doi: 10.3389/fphar.2024.1382094

PAR2 activation on human tubular epithelial cells engages converging signaling pathways to induce an inflammatory and fibrotic milieu

2024

Journal Article

Modulation of Adverse Health Effects of Environmental Cadmium Exposure by Zinc and Its Transporters

Cirovic, Ana, Cirovic, Aleksandar, Yimthiang, Supabhorn, Vesey, David A. and Satarug, Soisungwan (2024). Modulation of Adverse Health Effects of Environmental Cadmium Exposure by Zinc and Its Transporters. Biomolecules, 14 (6) 650, 650. doi: 10.3390/biom14060650

Modulation of Adverse Health Effects of Environmental Cadmium Exposure by Zinc and Its Transporters

2024

Journal Article

Corrigendum for the article Clin Nephrol. 2022; 98: 198-204

Dheda, S., Min, H., Vesey, D.A., Hawley, C., Johnson, D.W., Dimeski, G., Healy, H. and Fahim, M. (2024). Corrigendum for the article Clin Nephrol. 2022; 98: 198-204. Clinical Nephrology, 101 (5), 262-262. doi: 10.5414/cn110656cor

Corrigendum for the article Clin Nephrol. 2022; 98: 198-204

2024

Journal Article

The pathogenesis of albuminuria in cadmium nephropathy

Satarug, Soisungwan, Vesey, David A., Gobe, Glenda C. and Phelps, Kenneth R. (2024). The pathogenesis of albuminuria in cadmium nephropathy. Current Research in Toxicology, 6 100140, 100140. doi: 10.1016/j.crtox.2023.100140

The pathogenesis of albuminuria in cadmium nephropathy

2023

Journal Article

Estimation of the cadmium nephrotoxicity threshold from loss of glomerular filtration rate and albuminuria

Satarug, Soisungwan, Vesey, David A., Khamphaya, Tanaporn, Pouyfung, Phisit, Gobe, Glenda C. and Yimthiang, Supabhorn (2023). Estimation of the cadmium nephrotoxicity threshold from loss of glomerular filtration rate and albuminuria. Toxics, 11 (9) 755. doi: 10.3390/toxics11090755

Estimation of the cadmium nephrotoxicity threshold from loss of glomerular filtration rate and albuminuria

2023

Conference Publication

Evaluating kidney fibrosis using in vivo 1h magnetic resonance spectroscopy in patients with chronic kidney disease and live donors

Humphries, Tyrone, Dong, Xin, Watson, Julia, Mountford, Carolyn, Ellis, Robert, Vesey, David, Galloway, Graham, Gobe, Glenda and Francis, Ross (2023). Evaluating kidney fibrosis using in vivo 1h magnetic resonance spectroscopy in patients with chronic kidney disease and live donors. 58th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN), Christchurch, New Zealand, 4–6 September 2023. Richmond, VIC Australia: John Wiley & Sons.

Evaluating kidney fibrosis using in vivo 1h magnetic resonance spectroscopy in patients with chronic kidney disease and live donors

2023

Journal Article

Gender differences in the severity of cadmium nephropathy

Yimthiang, Supabhorn, Vesey, David A., Gobe, Glenda C., Pouyfung, Phisit, Khamphaya, Tanaporn and Satarug, Soisungwan (2023). Gender differences in the severity of cadmium nephropathy. Toxics, 11 (7) 616, 1-15. doi: 10.3390/toxics11070616

Gender differences in the severity of cadmium nephropathy

2023

Journal Article

Evidence linking cadmium exposure and β2-microglobulin to increased risk of hypertension in diabetes type 2

Yimthiang, Supabhorn, Pouyfung, Phisit, Khamphaya, Tanaporn, Vesey, David A., Gobe, Glenda C. and Satarug, Soisungwan (2023). Evidence linking cadmium exposure and β2-microglobulin to increased risk of hypertension in diabetes type 2. Toxics, 11 (6) 516. doi: 10.3390/toxics11060516

Evidence linking cadmium exposure and β2-microglobulin to increased risk of hypertension in diabetes type 2

2023

Conference Publication

Changes in energy metabolism in the kidney with tubulointerstitial fibrosis: an ex vivo whole tissue 2d-cosy approach

Humphries, Tyrone, Gobe, Glenda, Urquhart, Aaron, Vesey, David, Ellis, Robert, Galloway, Graham and Francis, Ross (2023). Changes in energy metabolism in the kidney with tubulointerstitial fibrosis: an ex vivo whole tissue 2d-cosy approach. 60th ERA Congress, Milan, Italy, 15-18 June 2023. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ndt/gfad063c_4344

Changes in energy metabolism in the kidney with tubulointerstitial fibrosis: an ex vivo whole tissue 2d-cosy approach

2023

Journal Article

Chronic kidney disease induced by cadmium and diabetes: a quantitative case-control study

Yimthiang, Supabhorn, Vesey, David A., Pouyfung, Phisit, Khamphaya, Tanaporn, Gobe, Glenda C. and Satarug, Soisungwan (2023). Chronic kidney disease induced by cadmium and diabetes: a quantitative case-control study. International Journal of Molecular Sciences, 24 (10) 9050, 1-15. doi: 10.3390/ijms24109050

Chronic kidney disease induced by cadmium and diabetes: a quantitative case-control study

2023

Journal Article

Cadmium-induced tubular dysfunction in type 2 diabetes: a population-based cross-sectional study

Satarug, Soisungwan, Yimthiang, Supabhorn, Pouyfung, Phisit, Khamphaya, Tanaporn and Vesey, David A. (2023). Cadmium-induced tubular dysfunction in type 2 diabetes: a population-based cross-sectional study. Toxics, 11 (4) 390, 1-14. doi: 10.3390/toxics11040390

Cadmium-induced tubular dysfunction in type 2 diabetes: a population-based cross-sectional study

2023

Journal Article

Identifying disease progression in chronic kidney disease using proton magnetic resonance spectroscopy

Humphries, Tyrone L.R., Vesey, David A., Galloway, Graham J., Gobe, Glenda C. and Francis, Ross S. (2023). Identifying disease progression in chronic kidney disease using proton magnetic resonance spectroscopy. Progress in Nuclear Magnetic Resonance Spectroscopy, 134-135, 52-64. doi: 10.1016/j.pnmrs.2023.04.001

Identifying disease progression in chronic kidney disease using proton magnetic resonance spectroscopy

2023

Journal Article

Cadmium-induced proteinuria: mechanistic insights from dose–effect analyses

Satarug, Soisungwan, Vesey, David A. and Gobe, Glenda C. (2023). Cadmium-induced proteinuria: mechanistic insights from dose–effect analyses. International Journal of Molecular Sciences, 24 (3) 1893, 1-14. doi: 10.3390/ijms24031893

Cadmium-induced proteinuria: mechanistic insights from dose–effect analyses

2023

Journal Article

Health risk in a geographic area of Thailand with endemic cadmium contamination: focus on albuminuria

Satarug, Soisungwan, Vesey, David A., Gobe, Glenda C., Yimthiang, Supabhorn and Buha Đorđević, Aleksandra (2023). Health risk in a geographic area of Thailand with endemic cadmium contamination: focus on albuminuria. Toxics, 11 (1) 68, 68. doi: 10.3390/toxics11010068

Health risk in a geographic area of Thailand with endemic cadmium contamination: focus on albuminuria

2023

Journal Article

Estimation of health risks associated with dietary cadmium exposure

Satarug, Soisungwan, Vesey, David A., Gobe, Glenda C. and Phelps, Kenneth R. (2023). Estimation of health risks associated with dietary cadmium exposure. Archives of Toxicology, 97 (2), 329-358. doi: 10.1007/s00204-022-03432-w

Estimation of health risks associated with dietary cadmium exposure

2022

Journal Article

The validity of benchmark dose limit analysis for estimating permissible accumulation of cadmium

Satarug, Soisungwan, Vesey, David A., Gobe, Glenda C. and Đorđević, Aleksandra (2022). The validity of benchmark dose limit analysis for estimating permissible accumulation of cadmium. International Journal of Environmental Research and Public Health, 19 (23) 15697, 1-15. doi: 10.3390/ijerph192315697

The validity of benchmark dose limit analysis for estimating permissible accumulation of cadmium

2022

Journal Article

Targeted biomarkers of progression in chronic kidney disease

Owens, Evan Paul, Healy, Helen Grania, Vesey, David Alan, Hoy, Wendy Elizabeth and Gobe, Glenda Carolyn (2022). Targeted biomarkers of progression in chronic kidney disease. Clinica Chimica Acta, 536, 18-28. doi: 10.1016/j.cca.2022.08.025

Targeted biomarkers of progression in chronic kidney disease

2022

Journal Article

The NOAEL equivalent of environmental cadmium exposure associated with gfr reduction and chronic kidney disease

Satarug, Soisungwan, Đorđević, Aleksandra Buha, Yimthiang, Supabhorn, Vesey, David A. and Gobe, Glenda C. (2022). The NOAEL equivalent of environmental cadmium exposure associated with gfr reduction and chronic kidney disease. Toxics, 10 (10) 614, 1-16. doi: 10.3390/toxics10100614

The NOAEL equivalent of environmental cadmium exposure associated with gfr reduction and chronic kidney disease

2022

Conference Publication

Identifying biochemical changes in the kidney using nuclear magnetic resonance in an adenine-diet chronic kidney disease mouse model

Humphries, Tyrone, Gobe, Glenda, Urquhart, Aaron, Galloway, Graham, Vesey, David and Francis, Ross (2022). Identifying biochemical changes in the kidney using nuclear magnetic resonance in an adenine-diet chronic kidney disease mouse model. 57th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN), 0nline, 17–19 October 2022. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/nep.14099

Identifying biochemical changes in the kidney using nuclear magnetic resonance in an adenine-diet chronic kidney disease mouse model

Funding

Past funding

  • 2013 - 2015
    The application of adipose-derived stem cells and stem cell secretions to the treatment of renal disease.
    UQ Academic Title Holder Research Fund
    Open grant
  • 2010 - 2013
    Enhancing erythropoietin therapy in ischaemia-reperfusion injury of heart and kidney
    NHMRC Project Grant
    Open grant
  • 2010 - 2012
    Protease activated receptor 2 antagonist in inflammatory disease
    NHMRC Development Grant
    Open grant
  • 2009 - 2012
    Protease Activated Receptor 2 : A New Drug Target For Inflammatory Diseases and Cancer
    NHMRC Project Grant
    Open grant

Supervision

Availability

Associate Professor David Vesey is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

For media enquiries about Associate Professor David Vesey's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au